Literature DB >> 15043573

Recombinant glycophorins C and D as tools for studying Gerbich blood group antigens.

Alissa Schawalder1, Marion E Reid, Karina Yazdanbakhsh.   

Abstract

BACKGROUND: The Gerbich blood group system antigens are carried on glycophorin C (GPC) and glycophorin D (GPD) and variants thereof. These glycoproteins have been expressed in a heterologous system to study the individual antigens and to determine whether Ana is antithetical to Ge2. STUDY DESIGN AND METHODS: cDNAs encoding GPC, GPD, GPC.Yus, GPC.Ge, GPC.Lsa, and GPD.Lsa were transfected and stably expressed in a human embryonic kidney cell line (293T). Individual Gerbich antigens were analyzed with MoAbs and human polyclonal antibodies by flow cytometry and immunoblotting. Recombinant GPD and GPD.Ana were expressed transiently and analyzed for expression of Ge2 and Ana antigens.
RESULTS: All recombinant variants were detected with sialidase-resistant and -sensitive anti-Ge2, anti-Ge3, and anti-Ge4. Ge4 antigen expression was depressed in GPC.Ls(a) transfectants as well as on Ls(a+) RBCs. GPD.An(a) recombinant protein expressed Ana and Ge2 antigens.
CONCLUSION: Cell lines stably expressing glycosylated Gerbich proteins were developed in a heterologous system by transfecting individual variant forms of GPC and GPD. Unexpectedly, it was found that Ge4 antigen is reduced in both the GPC.Ls(a) recombinant and the Ls(a+) RBCs. It was also shown that Ana and Ge2 antigens were expressed on a single GPD.An(a) protein and, therefore, they cannot be antithetical.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15043573     DOI: 10.1111/j.1537-2995.2003.03297.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  2 in total

1.  The structures of glycophorin C N-glycans, a putative component of the GPC receptor site for Plasmodium falciparum EBA-140 ligand.

Authors:  David J Ashline; Maria Duk; Jolanta Lukasiewicz; Vernon N Reinhold; Elwira Lisowska; Ewa Jaskiewicz
Journal:  Glycobiology       Date:  2014-12-30       Impact factor: 4.313

2.  When recombinant proteins can replace rare red cells in immunohematology workups.

Authors:  Willy A Flegel; Kshitij Srivastava
Journal:  Transfusion       Date:  2021-05-31       Impact factor: 3.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.